Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Aclaris Therapeutics, Inc. (ACRS) Debt to Equity Ratio data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$7.83M |
|
$-64.92M |
|
$7.28M |
|
$0.54M |
|
$84.20M |
|
$-76.38M |
|
$11.45M |
|
$-64.92M |
|
$-64.92M |
|
$-64.92M |
|
$-64.92M |
|
$-64.92M |
|
$-64.92M |
|
$-76.38M |
|
$-75.92M |
|
122.56M |
|
122.56M |
|
$-0.53 |
|
$-0.53 |
|
| Balance Sheet Financials | |
$96.32M |
|
$0.76M |
|
$64.14M |
|
$160.46M |
|
$28.64M |
|
-- |
|
$28.73M |
|
$57.38M |
|
$103.08M |
|
$103.08M |
|
$103.08M |
|
120.50M |
|
| Cash Flow Statement Financials | |
$-47.11M |
|
$48.37M |
|
$-5.86M |
|
$24.57M |
|
$19.96M |
|
$-4.61M |
|
$12.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.36 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
6.93% |
|
-975.91% |
|
-975.91% |
|
-970.11% |
|
-829.58% |
|
-829.58% |
|
$-47.22M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
1.41 |
|
259.55 |
|
-62.98% |
|
-62.98% |
|
-40.46% |
|
-62.98% |
|
$0.86 |
|
$-0.39 |
|
$-0.38 |
|